Vaccine effectiveness and duration of protection of COVID-19 mRNA vaccines against Delta and Omicron BA.1 symptomatic and severe COVID-19 outcomes in adults aged 50 years and over in France

The emergence of SARS-CoV-2 variants calls for continuous monitoring of vaccine effectiveness (VE). We estimated the absolute effectiveness of complete 2-dose primary vaccination and booster vaccination with COVID-19 mRNA vaccines, and the duration of protection against Delta and Omicron BA.1 sympto...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamandjou Tchuem, Cynthia Raissa, Auvigne, Vincent, Vaux, Sophie, Montagnat, Charline, Paireau, Juliette, Monnier Besnard, Stéphanie, Gabet, Amélie, Benhajkassen, Nabil, Le Strat, Yann, Parent Du Chatelet, Isabelle, Levy-Bruhl, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968619/
https://www.ncbi.nlm.nih.gov/pubmed/36870880
http://dx.doi.org/10.1016/j.vaccine.2023.02.062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968619/
https://www.ncbi.nlm.nih.gov/pubmed/36870880
http://dx.doi.org/10.1016/j.vaccine.2023.02.062

Ejemplares similares